Sunshine Easy Company
Sunshine Easy Company is family owned and operated. Mr. Jim Wu, the President of Sunshine Easy Company, is a business professional with over 25 years’ experience in the healthcare industry including developing, implementing, managing, and enhancing new start-up companies in both China and U.S.
Mr. Wu has an extensive background in importing and exporting, sourcing and outsourcing, identifying new markets for established products, setting up distribution networks, and training and coaching of international business cultures. He has strong business development, commercial, and operations experience in USA, China and Internationally. He has an approved history in facilitating partnerships between China and U.S. businesses.
His experience includes developing new business opportunities for the small and mid-sized business by increasing imports/exports; designing international business promotion programs; and implementing China specific PR and marketing strategic plans. He also has significant experience with setting government relations strategies to promote and protect American business interests in China.
Sunshine Easy Company is an initial importer of medical devices approved by FDA and Medical Device Distributor in Texas. With headquarters in Houston and offices in Beijing & Shanghai, China, we can assist our U.S. clients to purchase from Chinese suppliers in the most effective and efficient way and help our Chinese sellers promote their medical devices in the United States.
Meet Our Team
Mr. Wu has been involved in the investment, healthcare, and international trade industries for over 25 years. He has extensive experience in international trade import and export, procurement and outsourcing, international business development, expanding product markets, establishing distribution networks, and international business cultural consulting. He is the founder of SaniMed Science Group, a distinguished Angel, and Early-Stage Investment Company in the USA, specializing in Health Tech industry. He is Director of Business Development of TomoWave Medical Group. He is the President of the White Mountain Medical Foundation, which promotes medical information exchange and education opportunities globally. He is Advisor of Beijing University Health Science Center Alumni Association, and the Board Member of Leadership Committee of Joint Institute between Michigan University Medicine and Peking University Health Science Center. Mr. Jim Wu, as the Founder of TomoWave Medical Group, has been accepted to the Health Tech Fall 2023 FI Core Program by The Founder Institute, which spans over 200 cities worldwide and encompasses more than 6,800 alumni companies across six continents. Mr. Wu was born and raised in China and earned a M.D. from the Medical School of Peking University, as well as an MBA from Bauer Business School at the University of Houston.
Dr. Alexander, known as the "Father of International Biomedical Optoacoustic Imaging," has dedicated over 20 years to the research and industrial translation of biomedical optoacoustic imaging technology. He has received funding of nearly $20 million from institutions such as the National Institutes of Health (NIH) and has applied for 21 patents, including the world's first optoacoustic patent titled "Method and System for Optoacoustic Imaging." He has also published 11 monographs and over 200 research papers. He has been honored with the Berthold Leibinger Innovations Prize and the James Smith Award from the International Photoacoustic and Photothermal Association. Currently, Dr. Alexander serves as the CEO and CTO of TomoWave Laboratories, Inc., where he focuses on the development and commercialization of high-resolution, high-contrast, and high-sensitivity 3D optoacoustic tomography (OAT) technology for oncology and biology. He also holds the positions of CEO and General Manager at TomoWave (Suzhou) Medical Imaging Co., Ltd., an adjunct professor in the Department of Biomedical Engineering at the University of Houston and a Distinguished Professor of Medical Imaging at Guangzhou Medical University. Furthermore, Dr. Alexander has held various positions throughout his career, including being a board member and Chief Technology Officer (Vice President of Medical Technologies) at Seno Medical Instruments, Director of the Optoacoustic Imaging and Spectroscopy Laboratory at the Biomedical Engineering Center of the University of Texas Medical Branch at Galveston, adjunct assistant professor at the College of Optometry at the University of Houston, adjunct assistant professor in the Department of Electrical and Computer Engineering at Rice University, and the Santander Chair of Excellence in Electronics at Carlos III University of Madrid. Dr. Alexander graduated from the Moscow Engineering Physics Institute with a bachelor's degree in theoretical and experimental physics in 1978, from the Moscow Engineering Physics Institute with a master's degree in ultrafast laser spectroscopy of biomolecules in 1980, and from the Institute of Spectroscopy of the Soviet Academy of Sciences with a doctoral degree in spectroscopy, photochemistry, and biophysics in 1986.
Jianlin Song, M.D., J.D., graduated from the top medical school in Beijing, China, and began her professional life as a physician. Her education and work experience in medicine provide her with a solid background and extensive knowledge to represent companies and individual practitioners in the life sciences and health care industries after she entered the legal profession. During her 17-year legal career, Dr. Song has defended manufacturers of a very broad spectrum of life science products, from food supplements and dental adhesives to prescription drugs and medical devices. She also has represented clinical and diagnostic laboratories and medical, dental and nursing practitioners in professional malpractice cases and licensing disputes. In recent years she began representing assisted living facilities in elder abuse litigation. Dr. Song’s many successes include a number of reported no-liability judgments for medical device manufacturers and life science providers, a dismissal of a Dental Board accusation after 10 sessions of administrative hearing spanning over four months, and multiple successful settlements in cases with multimillion-dollar demands. In addition to her litigation practice, Dr. Song regularly advises domestic and international companies on FDA regulations, CLIA regulations and other regulations in the life sciences industries. She has been a frequent author and speaker on these issues.